Search research articles
Contact Us
Filters
Showing results (171-180 of 935) with videos related to
Page
of 94
Sort By:
Plos Genetics
|
October 5, 2018
A systems biology approach uncovers the core gene regulatory network governing iridophore fate choice from the neural crest
Kleio Petratou, Tatiana Subkhankulova, James A Lister, et al.
Haematology and Blood Transfusion
|
January 1, 1983
The clinical pharmacology of cytosine arabinoside
M L Slevin, E M Piall, G W Aherne, et al.
Medical and Pediatric Oncology
|
January 1, 1982
The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy
M L Slevin, E M Piall, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1983
Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusion
M L Slevin, E M Piall, G W Aherne, et al.
Pesticides Monitoring Journal
|
September 1, 1974
Distribution of PCB and p,p'-DDE residues in Atlantic herring (Clupea harengus harengus) and yellow perch (Perca flavescens) in Eastern Canada--1972
V Zitko, P M Choi, D J Widish, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma
A Rohatiner, M L Slevin, H S Dhaliwal, et al.
Cancer Genetics and Cytogenetics
|
March 1, 1996
Acute myelogenous leukemia with dup(1)(p22p36),dup(1)(p22p36): a novel case?
S Porter, A M Walker, T A Lister, et al.
Developmental Biology
|
December 21, 2005
Zebrafish Foxd3 is required for development of a subset of neural crest derivatives
James A Lister, Cynthia Cooper, Kim Nguyen, et al.
Development (Cambridge, England)
|
August 6, 1999
nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate
J A Lister, C P Robertson, T Lepage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1992
Role of additional radiotherapy in advanced stages of Hodgkin's disease
J H Meerwaldt, C N Coleman, R I Fischer, et al.
Page
of 94
Search research articles
Search
Showing results (171-180 of 935) with videos related to
Sort By:
Page
of 94
Plos Genetics
|
October 5, 2018
A systems biology approach uncovers the core gene regulatory network governing iridophore fate choice from the neural crest
Kleio Petratou, Tatiana Subkhankulova, James A Lister, et al.
Haematology and Blood Transfusion
|
January 1, 1983
The clinical pharmacology of cytosine arabinoside
M L Slevin, E M Piall, G W Aherne, et al.
Medical and Pediatric Oncology
|
January 1, 1982
The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy
M L Slevin, E M Piall, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1983
Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusion
M L Slevin, E M Piall, G W Aherne, et al.
Pesticides Monitoring Journal
|
September 1, 1974
Distribution of PCB and p,p'-DDE residues in Atlantic herring (Clupea harengus harengus) and yellow perch (Perca flavescens) in Eastern Canada--1972
V Zitko, P M Choi, D J Widish, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma
A Rohatiner, M L Slevin, H S Dhaliwal, et al.
Cancer Genetics and Cytogenetics
|
March 1, 1996
Acute myelogenous leukemia with dup(1)(p22p36),dup(1)(p22p36): a novel case?
S Porter, A M Walker, T A Lister, et al.
Developmental Biology
|
December 21, 2005
Zebrafish Foxd3 is required for development of a subset of neural crest derivatives
James A Lister, Cynthia Cooper, Kim Nguyen, et al.
Development (Cambridge, England)
|
August 6, 1999
nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate
J A Lister, C P Robertson, T Lepage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1992
Role of additional radiotherapy in advanced stages of Hodgkin's disease
J H Meerwaldt, C N Coleman, R I Fischer, et al.
Page
of 94